Study ID: NC-100

Study Title

A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

Teva Identifier

NC-100

ClinicalTrials.gov Identifier

NCT00203073

Study Status

Completed

Trial Condition(s)

Relapsing Remitting Multiple Sclerosis

Interventions

Drug: glatiramer acetate 20 mg | Drug: glatiramer acetate 20 mg, with mitoxantrone

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
neurology icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 55 Years

Trial Duration

06/01/2003 - 04/01/2005

Phase

Phase 2

Study Type

Interventional